Dexcom Reports Strong Q4 and Full-Year 2025 Financial Results, Beats Estimates Despite Stock Dip

Q4 2025 revenue:
$1.26 billion, up 13% YoY, beat estimates of $1.24 billion12345

Q4 2025 EPS:
$0.68, beat forecasts of $0.65 by 4.62%135

Full-year 2025 revenue:
$4.66 billion, up 16% YoY45

Full-year 2025 GAAP net income:
$836.3 million, EPS $2.0945

Q4 gross margin:
63.5%, operating income $331.5 million (26.3% of revenue)35

U.S. revenue up 11% to $892 million, international up 18% to $368 million35

2026 revenue guidance:
$5.16-$5.25 billion (11-13% growth)3

Stock fell 4.45% in after-hours trading post-earnings3

Sources:

1. https://www.zacks.com/stock/news/2864967/dexcom-dxcm-q4-earnings-and-revenues-top-estimates

2. https://investors.dexcom.com/news/news-details/2026/Dexcom-Reports-Fourth-Quarter-and-Fiscal-Year-2025-Financial-Results/default.aspx

3. https://www.investing.com/news/transcripts/earnings-call-transcript-dexcom-q4-2025-beats-forecasts-stock-dips-93CH-4504180

4. https://www.stocktitan.net/sec-filings/DXCM/8-k-dexcom-inc-reports-material-event-197208501d45.html

5. https://finviz.com/news/310920/dexcom-stock-falls-despite-q4-earnings-beat-g7-rollout-drives-growth